Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92,448,158
-
Total 13F shares
-
8,239,628
-
Share change
-
-75,045
-
Total reported value
-
$133,896,000
-
Price per share
-
$16.25
-
Number of holders
-
45
-
Value change
-
-$2,329,398
-
Number of buys
-
33
-
Number of sells
-
14
Institutional Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q3 2018
As of 30 Sep 2018,
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,239,628 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, ORBIMED ADVISORS LLC, Fosun International Ltd, FMR LLC, Vanguard Group Inc, BlackRock Inc., KORNITZER CAPITAL MANAGEMENT INC /KS, FIL Ltd, GILDER GAGNON HOWE & CO LLC, and CONNING INC..
This page lists
45
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.